Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for Avidity Biosciences (RNA) over the last 5 years, with Q3 2025 value amounting to $269.6 million.

  • Avidity Biosciences' Change in Acquisitions & Divestments rose 9020.22% to $269.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 14142.15%. This contributed to the annual value of $586.4 million for FY2024, which is 7496.12% up from last year.
  • Per Avidity Biosciences' latest filing, its Change in Acquisitions & Divestments stood at $269.6 million for Q3 2025, which was up 9020.22% from $262.8 million recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Change in Acquisitions & Divestments ranged from a high of $330.2 million in Q1 2025 and a low of $3.0 million during Q4 2021
  • In the last 5 years, Avidity Biosciences' Change in Acquisitions & Divestments had a median value of $101.2 million in 2023 and averaged $130.4 million.
  • As far as peak fluctuations go, Avidity Biosciences' Change in Acquisitions & Divestments surged by 265766.67% in 2022, and later soared by 2777.71% in 2023.
  • Over the past 5 years, Avidity Biosciences' Change in Acquisitions & Divestments (Quarter) stood at $3.0 million in 2021, then soared by 2657.67% to $82.7 million in 2022, then grew by 27.78% to $105.7 million in 2023, then surged by 123.96% to $236.7 million in 2024, then grew by 13.86% to $269.6 million in 2025.
  • Its Change in Acquisitions & Divestments was $269.6 million in Q3 2025, compared to $262.8 million in Q2 2025 and $330.2 million in Q1 2025.